These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23585423)

  • 1. Effect of enalapril on glomerular filtration rate and proteinuria in children with chronic kidney disease: a randomized controlled trial.
    Hari P; Sahu J; Sinha A; Pandey RM; Bal CS; Bagga A
    Indian Pediatr; 2013 Oct; 50(10):923-8. PubMed ID: 23585423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ; Shahinfar S; Wells TG; Massaad R; Gleim GW; Santoro EP; Sisk CM; Lam C
    Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
    Webb NJ; Shahinfar S; Wells TG; Massaad R; Gleim GW; McCrary Sisk C; Lam C
    Pediatr Nephrol; 2013 May; 28(5):737-43. PubMed ID: 23207876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L; Rutkowski P; Renke M; Rutkowski B
    Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pentoxifylline in proteinuric chronic kidney disease: a systematic review and meta-analysis.
    Jiang X; Zhou S; Yao J; Kong X; Cui M
    J Nephrol; 2016 Oct; 29(5):653-62. PubMed ID: 26510426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy.
    Bauer JH; Reams GP; Hewett J; Klachko D; Lau A; Messina C; Knaus V
    Am J Kidney Dis; 1992 Nov; 20(5):443-57. PubMed ID: 1442757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.
    Fathallah-Shaykh SA; Flynn JT; Pierce CB; Abraham AG; Blydt-Hansen TD; Massengill SF; Moxey-Mims MM; Warady BA; Furth SL; Wong CS
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):571-7. PubMed ID: 25635034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of losartan and enalapril on serum uric acid and GFR in children with proteinuria.
    Bryant CE; Rajai A; Webb NJA; Hogg RJ
    Pediatr Nephrol; 2021 Oct; 36(10):3211-3219. PubMed ID: 33881639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliskiren add-on therapy effectively reduces proteinuria in chronic kidney disease: an open-label prospective trial.
    Wu MT; Tung SC; Hsu KT; Lee CT
    J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):271-7. PubMed ID: 23223162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease.
    Apperloo AJ; de Zeeuw D; Sluiter HE; de Jong PE
    BMJ; 1991 Oct; 303(6806):821-4. PubMed ID: 1932973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial.
    Elung-Jensen T; Heisterberg J; Sonne J; Strandgaard S; Kamper AL
    Eur J Clin Pharmacol; 2005 Apr; 61(2):87-96. PubMed ID: 15761754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor.
    Erley CM; Harrer U; Krämer BK; Risler T
    Kidney Int; 1992 May; 41(5):1297-303. PubMed ID: 1614045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalapril versus metoprolol in primary hypertension--effects on the glomerular filtration rate.
    Aurell M; Bengtsson C; Björck S
    Nephrol Dial Transplant; 1997 Nov; 12(11):2289-94. PubMed ID: 9394313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure response to conventional and low-dose enalapril in chronic renal failure.
    Elung-Jensen T; Heisterberg J; Kamper AL; Sonne J; Strandgaard S
    Br J Clin Pharmacol; 2003 Feb; 55(2):139-46. PubMed ID: 12580985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patients.
    Hoque R; Rahman MS; Iqbal M
    Bangladesh Med Res Counc Bull; 2009 Aug; 35(2):44-8. PubMed ID: 20120778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strict blood-pressure control and progression of renal failure in children.
    ; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
    N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late intervention in the remnant kidney model attenuates proteinuria but not glomerular filtration rate decline.
    Veitch MR; Thai K; Zhang Y; Desjardins JF; Kabir G; Connelly KA; Gilbert RE
    Nephrology (Carlton); 2021 Mar; 26(3):270-279. PubMed ID: 33179827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.